Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases

BACKGROUND: Pemetrexed and gemcitabine are both antimetabolites drugs approved in advanced non-small cell lung cancer (NSCLC). Their toxicity profile is well known. However, rare vascular side effects can occur such as vascular acrosyndromes and especially digital ischemia. The cause of this disfigu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Geier, Margaux, Babey, Hélène, Monceau-Baroux, Lucie, Quéré, Gilles, Descourt, Renaud, Cornec, Divi, Robinet, Gilles
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047622/
https://ncbi.nlm.nih.gov/pubmed/33869037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.644282
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki